Reuters logo
BRIEF-DBV Technologies completes blinded period in REALISE study of Viaskin Peanut
October 12, 2017 / 5:38 AM / 2 months ago

BRIEF-DBV Technologies completes blinded period in REALISE study of Viaskin Peanut

Oct 12 (Reuters) - DBV TECHNOLOGIES SA:

* REG-DBV TECHNOLOGIES ANNOUNCES COMPLETION OF BLINDED PERIOD IN REALISE STUDY OF VIASKIN PEANUT

* ‍97.5% OF PATIENTS CONTINUE TREATMENT IN OPEN-LABEL ARM OF REALISE STUDY​

* ‍PATIENTS WILL RECEIVE ACTIVE TREATMENT FOR A TOTAL OF 36 MONTHS​

* ‍COMPANY ANTICIPATES ANNOUNCING TOPLINE RESULTS FROM BLINDED PORTION OF REALISE TRIAL IN NOVEMBER 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below